此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer

2026年9月1日 更新者:David Freyer, DO, MS、Children's Hospital Los Angeles

The goal of this clinical trial is to improve the successful healthcare transition from pediatric to adult-focused care for childhood cancer survivors. The main questions it aims to answer are

  • Receipt of the intervention (vs. standard of care control) will increase the proportion of CCS achieving transition success to adult-focused survivorship care from 50% to 70%.
  • Receipt of the intervention (vs. standard of care control) will significantly reduce patients' unmet HRSN.
  • Intervention effectiveness will be moderated by sociodemographic factors (gender, race/ethnicity, insurance status), medical risk for late effects, HRSN burden, and patient-reported outcomes (quality of life, self-efficacy).

Researchers will compare those that receive intervention versus standard of care.

Patients are randomized to either an intervention group, receiving structured PN-led sessions and tailored support for care transitions, or a control group receiving standard follow-up by a nurse case manager. High-HRSN patients in the intervention arm get monthly check-ins and coordinated handoffs to adult care providers for continuity.

研究概览

地位

尚未招聘

条件

研究类型

介入性

注册 (估计的)

190

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • California
      • Los Angeles、California、美国、90027
        • Children's Hospital Los Angeles
        • 首席研究员:
          • David Freyer, DO, MS
        • 接触:
          • David Freyer, DO, MS
        • 副研究员:
          • Kimberly Miller, PhD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

不

描述

Inclusion Criteria:

  • diagnosed between the ages of 0-19 years with cancer or with any condition treated with cancer-like therapy.
  • currently in follow up at survivorship clinic or had a survivorship launch visit during the 12 months prior to study activation.
  • current age 20-29 (>95% of patients will be age 20-21)
  • meet LIFE Clinic transition readiness criteria, as clinically applied:
  • at least 5 years off treatment
  • medically stable
  • demonstrate a workable understanding of transition
  • have an identified primary care provider
  • able to speak and read English or Spanish
  • can provide informed consent.

Exclusion Criteria:

  • do not meet transition criteria
  • speak a language other than English or Spanish
  • are significantly impaired and cannot provide informed consent.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
有源比较器:Control
Recontacting patients by a nurse case manager after transition launch to determine transition success.
Standard of Care
实验性的:Navigation
Patients in the intervention have phone or video session with patient navigator at enrollment, 6, 12 and 18 months, or more frequently as dictated by high-risk social needs.
Follow Up

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Proportion of participants with Transition to Adult-Focused Survivorship Care
大体时间:Within 18 months following transition "launch" (study enrollment/baseline)

The proportion of participants who complete a qualifying adult-focused survivorship care visit, defined as:

For higher-risk survivors: a visit to the designated adult survivorship clinic For lower-risk survivors: a visit to a primary care provider that includes discussion of cancer history and/or late effects

Transition success is:

Self-reported by participants and Validated by study staff through contact with the receiving provider

Participants without a cancer-focused component to the visit (e.g., urgent care, vaccination-only visits) will not be considered successful transitions.

The outcome will be analyzed as a binary proportion (success vs. no success).

Within 18 months following transition "launch" (study enrollment/baseline)

次要结果测量

结果测量
措施说明
大体时间
Change in HRSN score from baseline to each follow-up time point in each study arm.
大体时间:Baseline to 18 months post-enrollment

Change in the number of unmet health-related social needs assessed using the CMS Accountable Health Communities (AHC) HRSN Screening Tool, including domains such as:

Housing instability, Food insecurity, Transportation barriers, Utility assistance needs, and Employment, education, mental health, and disability (supplemental items)

Count 6 (all social needs endorsed) to 0 (no social needs endorsed)

Baseline to 18 months post-enrollment
Change in Global Health-Related Quality of Life Score using Likert scale
大体时间:Baseline to 18 months post-enrollment

Change in patient-reported quality of life measured using the PROMIS Global Health Scale (10-item instrument), generating:

Physical health summary score Mental health summary score

0 (poor self reported health) -10 (best self reported health)

Baseline to 18 months post-enrollment
Change in General Self-Efficacy using Likert scale
大体时间:Baseline to 18 months post-enrollment

Change in perceived self-efficacy measured using the PROMIS General Self-Efficacy 10-item scale.

Scores reflect participants' confidence in managing health and behavior and are reported as standardized scores.

1 ( Lowest Confidence ) - 5 ( Highest Confidence )

Baseline to 18 months post-enrollment
Change in mean scores for Patient-Reported Access to and Experience with Healthcare as measures by CAHPS (Consumer Assessment of Healthcare Providers and Systems)
大体时间:Baseline to 18 months post-enrollment

Patient-reported measures derived from CAHPS (Consumer Assessment of Healthcare Providers and Systems) assessing:

Global rating of healthcare Access barriers Insurance-related difficulties

Outcomes reported as mean scores

Count 0 (Worst Possible Assessment) to 10 (Best Possible Assessment)

Baseline to 18 months post-enrollment
Change in count for barriers to care as measured by Likert scale barriers to care questionnaire
大体时间:Baseline to 18 months post-enrollment

39-item questionnaire that includes subscales of pragmatics, health knowledge and beliefs, expectations about care, skills, and marginalization.

Likert scale with 0-100 range, where 0 indicates the most barriers and 100 indicates no barriers.

Baseline to 18 months post-enrollment
Change in Emotional Social Support score using a Likert scale.
大体时间:Baseline to 18 months post-enrollment

Patient-reported social support measured using PROMIS short forms:

Emotional support (4 items each) Likert scale with 0-5 range, where 0 indicates the lowest social support and 5 indicates highest social support.

Baseline to 18 months post-enrollment
Change in Informational Support score using a Likert scale.
大体时间:Baseline to 18 months post-enrollment

Patient-reported social support measured using PROMIS short forms:

Informational support (4 items each)

Likert scale with 0-5 range, where 0 indicates the lowest social support and 5 indicates highest social support.

Baseline to 18 months post-enrollment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:David Freyer, DO, MS、Children's Hospital Los Angeles
  • 首席研究员:Kimberly Miller, PhD、Children's Hospital Los Angeles

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年10月1日

初级完成 (估计的)

2029年10月1日

研究完成 (估计的)

2030年9月1日

研究注册日期

首次提交

2026年6月2日

首先提交符合 QC 标准的

2026年6月2日

首次发布 (实际的)

2026年6月5日

研究记录更新

最后更新发布 (实际的)

2026年9月3日

上次提交的符合 QC 标准的更新

2026年9月1日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • CHLA-25-00386
  • R01CA303651 (美国 NIH 拨款/合同)
  • NCI-2025-09161 (其他标识符:CTRP)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅